Pneumonia laboratory findings: Difference between revisions

Jump to navigation Jump to search
Line 32: Line 32:
*The presence of the antigen in urine can be detected in 24 hours since the onset of the symptoms
*The presence of the antigen in urine can be detected in 24 hours since the onset of the symptoms
*The severity of [[Legionella]] disease increases the sensitivity of the urinary antigen test.
*The severity of [[Legionella]] disease increases the sensitivity of the urinary antigen test.
===Polymerase Chain Reaction===
*Polymerase chain reaction (PCR) is more useful in the diagnosis of viral and mycoplasma pneumonia.


===C-Reactive Protein===
===C-Reactive Protein===

Revision as of 21:32, 4 November 2014

Pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

Diagnostic Algorithm

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Imaging Findings

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pneumonia laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pneumonia laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pneumonia laboratory findings

CDC onPneumonia laboratory findings

Pneumonia laboratory findings in the news

Blogs on Pneumonia laboratory findings

Directions to Hospitals Treating Pneumonia

Risk calculators and risk factors for Pneumonia laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]

Overview

Laboratory findings such as leukocytosis are helpful for the diagnosis of bacterial pneumonia or to assess the status of the patient. Sputum samples need to be collected from every patient and gram staining and culture need to be performed to determine the exact pathogen causing the pneumonia. Other test include urine antigen test, CRP and procalcitonin.

Laboratory Tests

Routine Tests

Findings in routine blood tests are based on the severity of the disease and the cause, they can include the following:[1]

Sputum Gram Stain and Culture

  • Sputum samples should be obtained of all patients with productive cough.
  • Gram-stain and culture should be performed to assess the causative agent and guide the therapy.
  • In more than 80% of cases of pneumococcal pneumonia the sputum culture is positive.[2]

Blood Culture

  • Blood culture may be positive in cases of hematogenous spread, such as S. aureus pneumonia, and in around one fourth of patients with pneumococcal pneumonia.

Other Laboratory Tests

Urine Antigen Test [3]

  • Usually used to diagnose Legionella disease.
  • Useful also in the diagnosis of pneumococcus pneumonia, with a sensitivity of 74.6% and an association with worst clinical outcome.[4]
  • The presence of the antigen in urine can be detected in 24 hours since the onset of the symptoms
  • The severity of Legionella disease increases the sensitivity of the urinary antigen test.

Polymerase Chain Reaction

  • Polymerase chain reaction (PCR) is more useful in the diagnosis of viral and mycoplasma pneumonia.


C-Reactive Protein

  • C-reactive protein (CRP) may be helpful to differentiate between bacterial from viral pneumonia.
  • It has been reported that CRP is elevated (> 100 mg/L) in cases of bacterial pneumonia.[5]

Procalcitonin

  • Procalcitonin levels are associated with the severity of the pneumonia and the etiology.
  • It also helps to differentiate between bacterial and non-bacterial disease.[6]

References

  1. Solomon, Caren G.; Wunderink, Richard G.; Waterer, Grant W. (2014). "Community-Acquired Pneumonia". New England Journal of Medicine. 370 (6): 543–551. doi:10.1056/NEJMcp1214869. ISSN 0028-4793.
  2. Musher, Daniel M.; Thorner, Anna R. (2014). "Community-Acquired Pneumonia". New England Journal of Medicine. 371 (17): 1619–1628. doi:10.1056/NEJMra1312885. ISSN 0028-4793.
  3. Couturier MR, Graf EH, Griffin AT (2014). "Urine antigen tests for the diagnosis of respiratory infections: legionellosis, histoplasmosis, pneumococcal pneumonia". Clin Lab Med. 34 (2): 219–36. doi:10.1016/j.cll.2014.02.002. PMID 24856525.
  4. Zalacain R, Capelastegui A, Ruiz LA, Bilbao A, Gomez A, Uranga A; et al. (2014). "Streptococcus pneumoniae antigen in urine: diagnostic usefulness and impact on outcome of bacteraemic pneumococcal pneumonia in a large series of adult patients". Respirology. 19 (6): 936–43. doi:10.1111/resp.12341. PMID 24976113.
  5. Flanders, Scott A; Stein, John; Shochat, Guy; Sellers, Karen; Holland, Miles; Maselli, Judith; Drew, W.Lawrence; Reingold, Art L; Gonzales, Ralph (2004). "Performance of a bedside c-reactive protein test in the diagnosis of community-acquired pneumonia in adults with acute cough". The American Journal of Medicine. 116 (8): 529–535. doi:10.1016/j.amjmed.2003.11.023. ISSN 0002-9343.
  6. Johansson, Niclas; Kalin, Mats; Backman-Johansson, Carolina; Larsson, Anders; Nilsson, Kristina; Hedlund, Jonas (2014). "Procalcitonin levels in community-acquired pneumonia – correlation with aetiology and severity". Scandinavian Journal of Infectious Diseases. 46 (11): 787–791. doi:10.3109/00365548.2014.945955. ISSN 0036-5548.

Template:WH Template:WS